<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The aim of this study was to determine whether a combination of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning and albumin provides additive neuroprotective effects after transient global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Forty-three rats were assigned to 4 groups: the control group (group C; n=13; 3 died) received no treatment </plain></SENT>
<SENT sid="2" pm="."><plain>The albumin group (group A; n=10) received 2 g/kg of albumin for 5 minutes after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning group (group P; n=10) underwent 2 sevoflurane inhalations after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Each inhalation consisted of 5 minutes of 2.5% <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> and a subsequent washout time of 5 minutes </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning plus albumin group (group PA; n=10) received additional albumin during <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> groups, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by a bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> along with hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> and was maintained for 10 minutes </plain></SENT>
<SENT sid="7" pm="."><plain>Histologic and neurobehavioral outcomes were measured 7 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in CA1 pyramidal cells of the rat hippocampus </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Groups A, P, and PA showed an improved neurological outcome and contained more viable cells in the hippocampal CA1 area compared with group C (P&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>The number of apoptotic cells was significantly reduced in group PA compared with group C (P&lt;0.01) </plain></SENT>
<SENT sid="10" pm="."><plain>There was a significant difference in the Bcl-2, an antiapoptotic protein, expression between group C and other groups (P&lt;0.01) and between group A or P and group PA (P&lt;0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: A combination of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning and albumin increased the level of Bcl-2 expression compared with <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning or albumin alone, suggesting their combination might provide additional neuroprotection by decreasing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>